ArticleBlood research2026

Response-adapted lenalidomide-dexamethasone (LenDex) intensification after CyBorD induction for transplant-eligible multiple myeloma: the PIANO study.

Daisuke Minakata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.